White House Ramps Up Efforts to Eliminate China’s Chokehold on Rare Earths
The White House plans to expand its support for domestic rare-earth businesses to counter China’s near-monopoly on rare-earth minerals.
Senior officials informed a group of rare-earth companies at a recent meeting that the Trump administration intends to form public-private partnerships to boost domestic production and extend a minimum price guarantee to their products.
U.S. governmental support to the rare-earth sector would be similar to a recent investment deal with MP Materials, the company that owns the only active rare-earth mine in the United States.
In return for the deal, which begins in the last quarter of the year, the Pentagon will receive privileges in accessing the company’s products and owning a share of the upside profit above the guaranteed amount.
Rare earth, the 17 critical metals essential for converting magnetic energy into mechanical energy that underpins modern manufacturing, has become a focal point in the U.S.–China trade war.
Beijing has played the rare-earth card in the trade negotiations, seeking to lower the U.S. export controls on advanced semiconductor technology, which the regime deems a critical hurdle to its rise to global dominance.
Therefore, a stable price of rare earth elements backed by the U.S. government would make the domestic sector investable.
Peter Navarro, trade adviser to President Donald Trump, told Reuters that the administration would like to remove the U.S. vulnerabilities in the critical minerals industry “in ‘Trump Time,’ which is to say as fast as possible while maintaining efficiency.”
“Our goal is to build out our supply chains from mines to end-use products across the entire critical mineral spectrum, and the companies assembled at the meeting have the potential to play important roles in this effort,” Navarro added.
At the meeting, senior White House officials also informed businesses that Trump aims to replicate the speed of Operation Warp Speed during his first term. The initiative facilitated the development of the COVID-19 vaccine in less than a year.


